Page last updated: 2024-08-24

sertraline and Carcinoma, Non-Small Cell Lung

sertraline has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, F; Jiang, X; Liu, M; Lu, W; Lv, J; Pang, X; Shen, X; Wang, Q; Zhao, Z	1

Other Studies

1 other study(ies) available for sertraline and Carcinoma, Non-Small Cell Lung

Article	Year
Repurposing sertraline sensitizes non-small cell lung cancer cells to erlotinib by inducing autophagy. JCI insight, 2018, 06-07, Volume: 3, Issue:11 Topics: Adenylate Kinase; Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Drug Repositioning; Drug Resistance, Neoplasm; Drug Synergism; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Mice; Sertraline; Signal Transduction; Survival Analysis; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2018

Article

Year

Repurposing sertraline sensitizes non-small cell lung cancer cells to erlotinib by inducing autophagy.

JCI insight, 2018, 06-07, Volume: 3, Issue:11

Topics: Adenylate Kinase; Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Drug Repositioning; Drug Resistance, Neoplasm; Drug Synergism; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Mice; Sertraline; Signal Transduction; Survival Analysis; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2018